Estimates Revisions DexCom, Inc. BOERSE MUENCHEN
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.40 EUR | +6.27% |
|
+14.94% | +26.62% |
| 07-31 | DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| 07-31 | DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Consensus DexCom, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
